share_log

九洲药业(603456.SH):拟以1510万美元收购瑞华中山100%股权

Jiuzhou Pharmaceutical (603456.SH) plans to acquire 100% of Ruihua Zhongshan's shares for 15.1 million US dollars

Gelonghui Finance ·  Mar 12, 2023 18:35

Gelonghui March 12Jiuzhou Pharmaceutical (603456.SH) announced that in order to further enhance the company's CDMO preparation business capacity and speed up the implementation process of the company's "API + preparation" integrated platform, the company held the 22nd meeting of the Seventh Board of Directors and the 16th meeting of the Seventh Board of Supervisors on September 26th, 2022. The meeting examined and adopted the motion on changing the use of part of the funds raised in the fund-raising project to acquire 100% equity in the Zhongshan preparation factory owned by Sanders (China) and to increase its capital. It is agreed that the company will use the "CDMO preparation Project of Zhejiang Siwei Pharmaceutical Technology Co., Ltd." to raise 185 million yuan to acquire and increase the 100% equity interest in Zhongshan preparation Factory of Santex (China) Pharmaceutical Co., Ltd. ("Sanders (China)"). Zhongshan Pharmaceutical Factory is a newly established subsidiary of Sanderson (China), and will integrate the spun-off preparation manufacturing assets, production and management team into the new company (as of the date of announcement, the new company has been established, "Ruihua Zhongshan").

The company intends to acquire 100% equity interest in Ruihua Zhongshan at US $15.1 million (the final transaction price will be adjusted accordingly according to Ruihua Zhongshan's cash, liabilities and working capital on the delivery date). After the completion of the transaction, Ruihua Zhongshan will become a wholly owned subsidiary of Jiuzhou Pharmaceutical Co., Ltd. After the completion of the acquisition of Ruihua Zhongshan, the company will use the remaining raised funds to increase capital in Ruihua Zhongshan for the implementation of Ruihua Zhongshan CDMO preparation transformation and expansion project, all of the above capital increase is investment in fixed assets and meets the capitalization requirements.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment